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Abstract
Background: The objective of this study is to evaluate the prevalence of malocclusion and treatment needs in
transfusion dependent β-thalassemia major children.
Methods: One hundred transfusion dependent β-thalassemia major children visiting the Department of Pediatrics
were selected randomly and evaluated for malocclusion with Angle’s classification and Dewey’s modification. The
orthodontic treatment needs were also assessed using Grainger’s treatment priority index (TPI). The orthodontic
treatment needs were compared to normal children.
Results: The assessment of treatment needs revealed a higher prevalence of handicapping and severely handicapping
malocclusion in thalassemic children compared to normal children. The thalassemic patients were found to show
significantly more Angle’s Class II malocclusion (55 % vs. 15.7 %) when compared to normal children.
Conclusions: The higher prevalence of Angle’s Class II malocclusion and definitive malocclusion in thalassemic
children indicates the importance of preventive orthodontic procedures and efforts towards providing orthodontic
treatment to these children.
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Background
Orthodontics is the discipline within the framework of
dentistry which has for its purpose the diagnosis and
treatment of dentofacial abnormalities. This twofold pur-
pose is best expressed in those children who either ex-
hibit a dentition of extreme degree of malocclusion or
facial features of marked variations. When a child ex-
hibits both extremes, he deserves a thorough study of
his affliction. A child with thalassemia major (Cooley’s
anemia) falls in such group [1].
Thalassemia is one of the commonest genetic disorders
known to mankind. Thalassemia and other hemoglobinop-
athies are widespread globally. Thalassemia may have origi-
nated 50,000 years ago in a valley South of Italy and Greece
covered by Mediterranean Sea. The name thalassemia has
been derived from a Greek word “Thallus” meaning sea.
Thalassemia was recognized as a clinical entity by Cooley
and Lee. Thomas B. Cooley (1927), a pioneer pediatrician,
reported seven cases of splenomegaly with anemia, peculiar
bone changes, and characteristic facies [2]. Originally de-
scribed as a separate disease entity, this disease is now
known as Cooley’s anemia or β-thalassemia major. The
term “thalassemia” refers to a group of blood disorders
characterized by decreased synthesis of one of the two types
of polypeptide chain (α or β) which form the normal adult
hemoglobin molecule (HbA, α2 β2), resulting in decreased
filling of the red cells with hemoglobin and anemia. Based
on the genetic and clinical entities, thalassemia is classified
as homozygous, heterozygous, or compound heterozygous
[3]. The homozygous form (thalassemia major) exhibits
most severe clinical symptoms with marked orofacial
defects. The inheritance of beta thalassemia is an autosomal
recessive disorder with the chromosomal abnormality on
short arm of 11th chromosome (chromosome # 11p15.5).
The suggested causes of growth retardation and matur-
ation of the skeleton in thalassemic major patients include
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chronic anemia, hyperparathyroidism, and somatomedin
deficiency, a factor that stimulates cartilage growth [4–6].
The dentition shows protrusion, flaring, and spacing of
the anterior teeth, open bite, and other degrees of mal-
occlusion [7]. The tooth crown size and crown length in
thalassemic subjects are significantly smaller than those in
the unaffected groups [8, 9]. The literature shows in-
creased prevalence and severity of malocclusion (dentional
and craniofacial abnormalities) in thalassemic patients [8,
9]. Hattab FN1 observed increased overjet in 25.9 % of the
patients and more than half of the patients exhibited
frontal bossing, saddle nose, and to less extent maxillary
protrusion, giving in severe cases (16.7 %) a “chipmunk”-
like appearance [10]. The prevalence and severity of mal-
occlusion is also dependent on the medical treatment pro-
vided to the thalassemic children [11]. Patients with
craniofacial anomalies often have appearance concerns
and related social anxiety which can affect their quality of
life. Singh and Moss in their study assessed the psycho-
logical impact of facial and dental appearance in patients
with craniofacial anomalies in comparison to a general
population control group [12]. It is thus important to
study the prevalence and orthodontic treatment needs in
our population that may be different from other groups.
The treatment priority index (TPI) index was used in the
study because of its simple and efficient application in
epidemiological surveys of malocclusions without undue
cost and energy [13].
Thus, the aim of the present study was to evaluate the
prevalence of the type of malocclusion and to assess
orthodontic treatment needs in the thalassemic children.
The study was carried out with the following aims and
objectives:
1. To evaluate the prevalence of malocclusion in
transfusion-dependent beta thalassemia children
using Angle’s classification and Dewey’s modification
2. To assess the orthodontic treatment needs using
Grainger’s TPI
Methods
The study was conducted at the Unit of Orthodontics, Oral
Health Science Centre in collaboration with Thalassemia
ward at Department of Pediatrics, Advanced Pediatric
Centre (APC), Postgraduate Institute of Medical Education
and Research (PGIMER), Chandigarh. Appropriate ethical
clearance was granted to conduct the study by the board of
studies of the institution. The study comprised of one
hundred transfusion-dependent beta thalassemia major
children (71 males, 29 females) between the age range
of 12–17 years. The mean age of sample was
13.84 years. The children were selected on a random
basis from the patient regularly coming for transfusion
in the thalassemic ward at APC, PGIMER, Chandigarh.
The first 100 beta thalassemia patients visiting the de-
partment in the defined age group were assigned to the
examiner for evaluation of type of malocclusion and
TPI index, without the examiner’s choice. The exam-
iner was trained and standardized in the use of TPI.
The intraoral examination of all the patients was done
and recorded by the same examiner.
Selection criteria
The patients included in this study fulfilled the following
criteria:
(i) Diagnosed case of homozygous beta thalassemia
(thalassemia major), receiving regular blood
transfusion.
(ii) Patients 12–17 years of age.
(iii) Patient who had not undergone any kind of
orthodontic treatment.
(iv) Patient not affected by conditions like gross
physical or mental disability.
(v) The first 100 patients visiting the department
regularly for transfusion every month were
evaluated. They constituted the major portion of
the patients in the concerned age group visiting the
thalassemia clinic for regular transfusion.
The control group comprised a proportioned sample
from epidemiological survey of prevalence of malocclu-
sion in 12–17 years school children; 500 students in the
defined age group were examined randomly in the two
different schools in the vicinity without any priority, and
the data was recorded.
A Performa was used to record the various aspects of
malocclusion and to record the various parameters of
Grainger’s TPI index [14]. The Performa (TPI data collec-
tion form) was designed to include patient details, type of
malocclusion i.e. Angle’s classification, and parameters of
TPI index (first molar relation, horizontal and vertical in-
cisor relation, tooth displacement score, congenitally miss-
ing incisors, posterior crossbite, and any other defect.
A total of TPI scores were calculated, and the level of se-
verity was assessed according to malocclusion severity esti-
mate. Levels of severity of a malocclusion as established by
the malocclusion severity estimate (MSE) and used for the
present study are given below:
I. Virtually classic normal occlusion 0
II. Minor manifestations of malocclusion and treatment need is
slight
1–3
III. Definite malocclusion, but treatment elective 4–6
IV. Severe handicap, treatment highly desirable 7–9
V. Very severe handicap with treatment mandatory >10
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Table 1 Comparison of prevalence of Class I, Class II, and Class III malocclusion in thalassemic and normal children
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Intraexaminer and interexaminer variability and
reproducibility
The observations in TPI index of approximately 10 % of
the sample were graded after an interval of 1 week to
standardize the investigator for a reproducible result.
The investigator was trained for evaluation using TPI
index. Further, the observations of 10 % patients were
also graded by one of the experienced examiners so as
to test the interexaminer reproducibility which was
found to be satisfactory.
The means and percentages were calculated for the
different population groups. The comparison of popula-
tion means was done using “Z” test to compare the
prevalence of malocclusion and malocclusion traits be-
tween the two groups under study.
Results
Prevalence of malocclusion
The results in the present study show that significantly
less (p < 0.001) thalassemic children have Angle’s Class I
malocclusion (44.0 % vs 82.2 %) than normal children.
The thalassemic patients show significantly more Angle’s
Class II malocclusion (55 % vs 15.7 %) when compared
to normal children (Table 1).
Further within the Class I malocclusion group, Class I
type 1 malocclusion was significantly less (p < 0.001) in
thalassemic children when compared to normal (25 % vs
69.6 %).
In the Class II subgroup, Class II div 1 malocclusion
shows the maximum occurrence.
The prevalence of Class III malocclusion is less than
the normal population with only one case reported in
the present study (Table 1).
Assessment of overjet, prevalence of tooth displacement,
and buccal and lingual crossbite
In thalassemic children, a positive overjet was found in
99.0 % of patients and it was not different from normal
population (98.5 %). None of the thalassemic patients
showed overjet of 1 mm compared to 3.9 % of normal
children having overjet of 1 mm (p < 0.05). The preva-
lence of tooth displacement is more in thalassemic pa-
tients. The prevalence of buccal and lingual crossbite is
also more in thalassemic patients (Table 2).
Treatment needs assessment
TPI scores showed normal occlusion (TPI score 0) to be
significantly less (p < 0.001) in thalassemic children when
compared to normal children. On the other hand, defin-
ite malocclusion (TPI scores 4–6.99) was significantly
more in thalassemic children compared to normal chil-
dren. Similarly handicapping malocclusion (TPI scores
7–9.9) and severely handicapping malocclusion (TPI
scores >10) was significantly more (p < 0.05) prevalent in
thalassemic children than normal children (Table 3).
The comparison of TPI score of thalassemic children
in the present study shows 32 % in the no or minor mal-
occlusion groups, 36 % in the definite malocclusion
group, and 32 % in the handicapping and severely handi-
capping malocclusion group.
Similar comparison of TPI score of normal children in
the present study shows 77 % in the no or minor mal-
occlusion groups, 10 % in the definite malocclusion
group and 8 % in the handicapping and severely handi-
capping malocclusion group.
Discussion
The prevalence and severity of malocclusions in
transfusion-dependent thalassemic patients of the age
group 12–17 years was done as this is a common age
when orthodontic treatment is sought. The TPI was se-
lected for this evaluation as it has proved to be a useful
epidemiological indicator of malocclusion [15]. It has
been found to be highly reproducible and valid [16]. Ap-
plication of the TPI is practicable and requires less cler-
ical time when compared with the Occlusal Index (OI)
[17]. Thus, the TPI is a useful index for measuring need
for treatment and as an aid in the identification of chil-
dren who can benefit most from orthodontic treatment
[14].
The present study reported a ratio of 1:1.25:0.01 be-
tween angle Classes I, II, and III malocclusion, respect-
ively, in the thalassemia group which contrasted to a
normal population ratio of 5.2:1:0.01. Pusaksrikit et al.
reported the ratio between various angle classes, i.e., I,
II, III as 2.7:1:0 which contrasted to a normal population
pattern of 3:1:1 [18].
Giuseppina in a study reported Class I, II, III maloc-
clusions, and asymmetries in 40.4, 29.2, 3.2 and 27.1 %
of the sample, respectively. The objective need for
Table 2 Comparison of prevalence of tooth displacement, buccal and lingual crossbite, and overjet in thalassemic and normal
children


























8 30 42 10 10 17 20 17 21 0 48 32 14 6
Normal children 30 18 8 5 2 2 3 3 4 4 83 8 4 1
Gupta et al. Progress in Orthodontics  (2016) 17:7 Page 4 of 6
orthodontic treatment (grades 4 and 5 of IOTN) was
registered in 1077 subjects (41.2 %) [19].
The higher prevalence of Class II malocclusion in thal-
assemic children in the past has been attributed both to
marrow hyperplasia occurring due to chronic anemia,
resulting in maxillary prominence and also due to man-
dibular retrusion occurring because of generalized
growth retardation in the thalassemic children by differ-
ent authors [20–23].
In the present study, the assessment of malocclusion
using TPI scores in normal population shows no or
minor malocclusion in 77 % cases. This is similar to re-
sults of studies by Bhardwaj et al., Shivakumar et al.,
Esa et al., and van Wyk et al. These studies using
Dental Aesthetic Index scores show no or minor mal-
occlusion in the range of 60 to 80 % in the normal
population [24–27]. Ugur et al. conducted a study to
evaluate the prevalence of malocclusion and to assess
the need for orthodontic treatment among 6–10-year-
old Turkish primary school children. The TPI was used
to record and measure the malocclusions; 40.38 % of
the observed population showed normal occlusion,
21.85 % had minor manifestations of malocclusion and
treatment need was slight, 25.17 % of the subjects
showed definite malocclusion, 7.54 % had severe mal-
occlusion, and 5.06 % had a very severe handicap with
a mandatory treatment requirement. Thus, according
to this study, there is definite need for orthodontic
treatment in 37 % of individuals [28].
The present study indicates that 68 % of the thalasse-
mic patients definitely need orthodontic treatment
which is 18 % for normal population. Comparison with
any of the previous studies show that the prevalence of
malocclusion in thalassemic patients is also much more
than that in the normal population. The assessment of
treatment needs revealed a higher prevalence of handi-
capping and severely handicapping malocclusion in thal-
assemic patients compared to normal children. This
necessitates the need for providing orthodontic treat-
ment to these children.
In the present study, occurrence of Class III malocclu-
sion was an interesting observation. It is difficult to ex-
plain this observation as there was no familial history
and literature does not support the occurrence of Class
III in thalassemic patients.
The present study was conducted in an environment
where the patients are regularly transfused and
transfusion is started at very early stages. The blood
hemoglobin levels are regularly monitored and main-
tained. This decreases the extent of malocclusion. Thus,
we may expect more severe malocclusions in other envi-
ronments where the facilities for these patients are not
very favorable. This may further increases the need for
orthodontic treatment.
Conclusions
 The prevalence of Class II malocclusion is higher in
thalassemic children.
 Overall definite malocclusion, handicapping
malocclusion, and severely handicapping
malocclusion is more in thalassemic children than
that in normal children, so our efforts should be
directed towards providing orthodontic treatment to
these children.
 Further, the advancement of medical treatment
modalities has led to an increase in life expectancy
of these children and demand for orthodontic
treatment may increase in future.
 These results underscore the high percentage of
orthodontic treatment need in thalassemic patients
and indicate the importance of preventive
orthodontic procedures.
Since the sample size of the thalassemic group in the
study was not very large, further studies may be con-
ducted to confirm the results of the present study. The
baseline information outlined in the present study can
be appropriately utilized for the future planning to meet
the orthodontic treatment need among the population.
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